Schmidbauer Stephan L, Seyfried Timo F
Department of Anesthesiology, University Hospital Regensburg, 93053 Regensburg, Germany.
Department of Anesthesiology, Ernst von Bergmann Hospital, 14467 Potsdam, Germany.
J Clin Med. 2022 Jul 2;11(13):3848. doi: 10.3390/jcm11133848.
Patient Blood Management (PBM) is a patient-centered, systemic and evidence-based approach. Its target is to manage and to preserve the patient's own blood. The aim of PBM is to improve patient safety. As indicated by several meta-analyses in a systematic literature search, the cell salvage technique is an efficient method to reduce the demand for allogeneic banked blood. Therefore, cell salvage is an important tool in PBM. Cell salvage is widely used in orthopedic-, trauma-, cardiac-, vascular and transplant surgery. Especially in cases of severe bleeding cell salvage adds significant value for blood supply. In cardiac and orthopedic surgery, the postoperative use for selected patients at the intensive care unit is feasible and can be implemented well in practice. Since the retransfusion of unwashed shed blood should be avoided due to multiple side effects and low quality, cell salvage can be used to reduce postoperative anemia with autologous blood of high quality. Implementing quality management, compliance with hygienic standards as well as training and education of staff, it is a cost-efficient method to reduce allogeneic blood transfusion. The following article will discuss the possibilities, legal aspects, implementation and costs of using cell salvage devices in an intensive care unit.
患者血液管理（PBM）是一种以患者为中心、系统且基于证据的方法。其目标是管理和保存患者自身的血液。PBM的目的是提高患者安全性。在系统文献检索中的多项荟萃分析表明，细胞回收技术是一种减少异体库血需求的有效方法。因此，细胞回收是PBM中的一项重要工具。细胞回收广泛应用于骨科、创伤、心脏、血管和移植手术。特别是在严重出血的情况下，细胞回收对血液供应具有重要价值。在心脏和骨科手术中，对重症监护病房的特定患者进行术后使用是可行的，并且在实践中可以很好地实施。由于未洗涤的引流血再输注会因多种副作用和低质量而应避免，细胞回收可用于通过高质量的自体血减少术后贫血。通过实施质量管理、遵守卫生标准以及对工作人员进行培训和教育，它是一种降低异体输血的经济有效方法。以下文章将讨论在重症监护病房使用细胞回收设备的可能性、法律方面、实施情况和成本。
